Do peptides help with hair loss (androgenetic alopecia)?
One peptide is graded for hair loss (androgenetic alopecia) on this page. The strongest grade is animal-only evidence, for GHK-Cu. It is weighed against the standard of care below, and the evidence table gives its grade and a note.
What is the standard of care for hair loss (androgenetic alopecia)?
Topical minoxidil for men and women; oral finasteride for men; low dose oral minoxidil off label; low level laser devices; hair transplantation for stable loss; check thyroid function, iron, and other causes when shedding is diffuse or sudden.
Any peptide below should be judged against this baseline, not against doing nothing. Talk to a licensed provider before replacing or adding to an established treatment.
Which peptides have been studied for hair loss (androgenetic alopecia)?
Ordered by strength of evidence for this use. Grades follow the methodology; each peptide page lists the individual studies.
| Peptide | Evidence for this use | Note |
|---|---|---|
| GHK-Cu | Evidence: Animal-only evidence | Reviews describe larger hair follicles and follicle cell effects in lab and animal studies; common in cosmetic serums, but no indexed human hair loss trial. [2] [3] |
Cost and access
Price ranges, lawful channels, and insurance notes for peptides graded here. State rules are in the legal guides by state.
Frequently asked questions
Do peptides work for hair growth?
Not in human trials so far. Copper peptide GHK-Cu, the peptide most used in hair serums, enlarged hair follicles and changed follicle cell activity in lab and animal studies, but no controlled human hair loss trial has been published, and no peptide is FDA approved for hair loss. Minoxidil and finasteride are the treatments with randomized trial evidence. [1] [2] [3] [5]
Is GHK-Cu better than minoxidil for hair loss?
There is no evidence that it is. A 2017 meta-analysis of randomized trials found topical minoxidil, oral finasteride in men, and low level laser therapy all beat placebo for pattern hair loss. GHK-Cu has no randomized human hair trial, so it has never been compared with minoxidil. [1] [3]
Is any peptide FDA approved for hair loss (androgenetic alopecia)?
No. None of the peptides graded for hair loss (androgenetic alopecia) is an FDA approved drug, so any use is outside an approved label and depends on the compounding and research status shown on each peptide page. [5]
Has any peptide been tested in a randomized trial for hair loss (androgenetic alopecia)?
No. The best evidence for any peptide graded for hair loss (androgenetic alopecia) is animal only evidence, so none has been shown to work in a randomized human trial for this use. [2] [3]
Does oral minoxidil work for hair loss?
It is used off label. Minoxidil tablets are FDA approved only for severe high blood pressure, and the label says hair growth is not an approved use. In a 24 week randomized trial in men, oral minoxidil 5 mg daily was not superior to 5% topical minoxidil on hair density; unwanted body hair affected 49% of the oral group. Our blog posts on oral minoxidil and minoxidil side effects cover the studies and the risks. [6] [7]
From the blog
- Minoxidil side effects: topical, oral, shedding, and pets
Minoxidil side effects differ by form: scalp irritation and unwanted facial hair with topical use, body hair and fluid retention with oral use. Plus shedding, pregnancy, and the danger to cats.
- Oral minoxidil for hair loss: evidence and side effects
Low-dose oral minoxidil is an off-label hair loss treatment. What the FDA label for the blood pressure tablet says, what the hair loss trials found, and the side effects they reported.
- Copper peptides for hair: what the studies show
Does GHK-Cu help with hair growth? Copper peptides enlarge hair follicles in lab and mouse studies, but no randomized trial of GHK-Cu alone for hair loss exists. How they compare with minoxidil.
- Topical vs injectable GHK-Cu: what the evidence shows
Topical GHK-Cu has small skin studies and is a lawful cosmetic. Injectable GHK-Cu has no human trial and no lawful compounding path. Evidence, absorption, safety, and legality compared.
Sources
- [1]The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis. J Am Acad Dermatol 2017PubMed 28396101, 2017
- [2]The human tri-peptide GHK and tissue remodelingPubMed 18644225, 2008
- [3]Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene dataPubMed 29986520, 2018
- [4]FDA prescribing information for Propecia (finasteride) tablets, via DailyMedFDA, 2025
- [5]Drugs@FDA: FDA-approved drugs databaseFDA
- [6]FDA prescribing information for minoxidil tablets USP, 2.5 mg and 10 mg, via DailyMedFDA
- [7]Oral minoxidil vs topical minoxidil for male androgenetic alopecia: a randomized clinical trialPubMed 38598226, 2024